Department of Urology, Bristol Royal Infirmary, Bristol, United Kingdom.

This email address is being protected from spam bots, you need Javascript enabled to view it

Prostate cancer is the third most common cancer worldwide and an increasing proportion of men are being diagnosed with localised disease. Urinary incontinence is uncommon in healthy men, but may develop as a result of curative treatment for prostate cancer. The optimal therapy remains undefined so the treatment associated morbidity is an important determinant in patient choice. Urinary incontinence may also develop from tumour progression during deferred treatment, sphincter involvement in advanced disease or surgery for symptomatic malignant bladder outlet obstruction. As urinary incontinence is known to have a significant impact on health related quality of life, we have reviewed the literature on incontinence related to prostate cancer and its treatment.

Written by:
Parsons BA, Evans S, Wright MP.   Are you the author?

Reference:
Maturitas. 2009 Aug 20;63(4):323-8.
doi:10.1016/j.maturitas.2009.06.005

PubMed Abstract
PMID:19615834

UroToday.com Prostate Cancer Section